JENNA RICHARDSON: Open Payments
NPI 1841875911 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,342 in 117 payments from 18 companies in 2025. Trend: 2023 $46 · 2024 $593 · 2025 $5,342
Food & beverage: $4,369Travel & lodging: $973
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 7 | $1,520 |
| ABBVIE INC. | 32 | $711 |
| Madrigal Pharmaceuticals | 9 | $441 |
| Ardelyx, Inc. | 10 | $394 |
| Phathom Pharmaceuticals, Inc. | 4 | $358 |
| Lilly USA, LLC | 8 | $322 |
| Janssen Biotech, Inc. | 5 | $285 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $269 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $198 |
| Gilead Sciences, Inc. | 5 | $167 |
Products named: REZDIFFRA, IBSRELA, VOQUEZNA, LINZESS, ENTYVIO, TREMFYA, XIFAXAN, MAVYRET.
Industry payments across TN — which companies pay providers there.
